- John Kerry: Israel-Palestinian peace deal paved for April
- India diplomat who touts women’s rights busted for $3 wage to nanny
- MSNBC host Ed Schultz paid $252K by unions in 2012-2013
- Korean War memorial ordered to take down Christian cross
- Billy Graham near death, ‘close to going home to be with the Lord’
- SeaTac, Wash.: City’s new $15 minimum wage heads to court
- Obama mulls support for Islamists in Syria, with conditions
- Obama ‘birther’ theories float, as Hawaii health director killed in crash
- U.S. drone faulted for killing 14 ‘innocent civilians’ at Yemen wedding
- GOP hopes taking shutdown off the table with budget deal will pay dividends
Drug maker agrees to largest-ever fraud settlement
GlaxoSmithKline LLC, a global health care company, agreed to plead guilty and pay $3 billion, the largest health care fraud settlement in U.S. history, after illegally marketing certain prescription drugs, Department of Justice officials announced Monday.
GSK agreed to pay $3 billion to resolve criminal and civil charges for promoting the drugs Paxil and Wellbutrin for uses not approved by the Food and Drug Administration — such as treating children for depression and treating adult patients for obesity, anxiety, addiction and Attention Deficit Hyperactivity Disorder.
The company also failed to report clinical data about the drug Avandia to the FDA.
It will pay $1 billion in criminal fines and forfeitures and another $2 billion to resolve allegations that it caused false claims to be submitted to federal health care programs — marking the largest health care fraud settlement in history, said deputy attorney general James Cole.
“Today’s multi-billion dollar settlement is unprecedented in both size and scope,” Mr. Cole said. “It underscores this administration’s firm commitment to protecting the American people and holding accountable those who commit health care fraud.”
The DOJ has recovered more than $10.2 billion in settlements, judgements, fines, restitution and forfeiture in health care fraud cases in the three years since President Obama's administration created a new health care fraud prevention team and a Medicare strike force.
Earlier this year, officials said they had uncovered the largest Medicare fraud scheme in history, arresting a ring of Dallas-area health care professionals on suspicion of collecting $375 billion for phony medical claims.
GSK agreed to plead guilty to a three-count criminal information, including two counts of introducing misbranded drugs, Paxil and Wellbutrin, into interstate commerce and one count of failing to report safety data about the drug Avandia to the Food and Drug Administration (FDA).
Under the terms of the plea agreement, GSK will pay a total of $1 billion, including a criminal fine of $956,814,400 and forfeiture in the amount of $43,185,600. The criminal plea agreement also includes certain non-monetary compliance commitments and certifications by GSK’s U.S. president and board of directors.
GSK’s guilty plea and sentence is not final until accepted by the U.S. District Court.
GSK will also pay $2 billion to resolve its civil liabilities with the federal government under the False Claims Act, as well as the states.The civil settlement resolves claims relating to Paxil, Wellbutrin and Avandia, as well as additional drugs, and also resolves pricing fraud allegations.
“For a long time, our health care system had been a target for cheaters who thought they could make an easy profit at the expense of public safety, taxpayers, and the millions of Americans who depend on programs like Medicare and Medicaid,” said Bill Corr, deputy secretary of the Department of Health and Human Services.
“But thanks to strong enforcement actions like those we have announced today, that equation is rapidly changing,” he said.
© Copyright 2013 The Washington Times, LLC. Click here for reprint permission.
About the Author
- A familiar fading feeling for McMahon in Connecticut
- Romney’s bid to undo health law faces hurdles
- Hill GOP presses Medicare probe
- Romney, Obama advisors butt heads over binders, Big Bird and “Romnesia”
- Outsiders abide by rules in Brown-Warren race
Latest Blog Entries
By Mangosuthu Buthelezi
Memories of a long brotherhood tempered in common struggle
- U.S. Navy-China showdown: Chinese try to halt U.S. cruiser in international waters
- House budget bargain faces Senate filibuster; Republicans line up to oppose
- Obama birther theories float, as Hawaii health director killed in crash
- Obama's Afghanistan experts stumped on U.S. death toll, war costs during hearing
- NAPOLITANO: A conspiracy so vast
- North Korea's official report on Jang Song Thaek
- Billy Graham near death, close to going home to be with the Lord
- PRUDEN: The last living witnesses; they wore the yellow star and remember the Nazi terror
- James Bond: The spy who is really an alcoholic
- Kim Jong-un consolidating power or losing grip on North Korea's military
Independent voices from the The Washington Times Communities
A conservative commentator and satirist takes on the worlds of politics and entertainment in pursuit of truth, justice and all things America.
Politics, economics, and business from a real world perspective.
Implement these actionable tips, how-to’s and best practices in 10 minutes or less to leverage online communications and technology for brand, business and career development.
Consummate traveler Todd DeFeo explores the unique stories that make destinations worth going to.
Extraordinary day at Redskins Park
White House pets gone wild!
Let it snow